Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Bavarian Nordic begins phase II study of RSV vaccine

Oct. 19, 2016

Rational Vaccines reports results from phase I trial of HSV vaccine

Oct. 19, 2016

Mutabilis discloses beta-lactamase inhibitors

Oct. 18, 2016

ZMapp beneficial but not superior to standard care in PREVAIL II Ebola virus disease trial

Oct. 14, 2016

ContraVir reports interim data from phase IIa trial of CMX-157 in HBV

Oct. 14, 2016

Paratek Pharmaceuticals signs agreement with USAMRIID for omadacycline research

Oct. 13, 2016

FDA approves Protein Sciences' Flublok influenza vaccine

Oct. 13, 2016

FDA grants QIDP and fast track designation to Viamet Pharmaceuticals' VT-1161

Oct. 13, 2016

EMA issues positive opinion on Atara Biotherapeutics' CMVpp65-CTL

Oct. 13, 2016

Taisho Pharmaceutical reports compounds useful for RSV infection

Oct. 11, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...